Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsShashvat Gupta, MD
Assistant Clinical ProfessorDownloadHi-Res Photo
About
Copy Link
Titles
Clinical Instructor, Internal Medicine
Appointments
Internal Medicine
Assistant Clinical ProfessorPrimary
Other Departments & Organizations
Education & Training
- Resident
- New York Medical college (2019)
Research
Copy Link
Publications
2026
Opportunistic Deep Learning-Derived Chamber Volumes And Lv Mass From Pet/ct Attenuation Ct Predict Heart-Failure Hospitalization: Evidence Synthesis Of A Multicenter Cohort
Kumar H, Rimza F, Sharma A, Gupta S. Opportunistic Deep Learning-Derived Chamber Volumes And Lv Mass From Pet/ct Attenuation Ct Predict Heart-Failure Hospitalization: Evidence Synthesis Of A Multicenter Cohort. Journal Of Cardiovascular Computed Tomography 2026, 20 DOI: 10.1016/j.jcct.2026.05.038.Peer-Reviewed Original ResearchMyocardial Extracellular Volume From Ct In Cardiac Amyloidosis: Agreement With Cmr And Feasibility Of One-Stop Coronary And Myocardial Assessment—Evidence Synthesis And Meta-Analysis Of Correlation
Sharma A, Kumar H, Rimza F, Gupta S. Myocardial Extracellular Volume From Ct In Cardiac Amyloidosis: Agreement With Cmr And Feasibility Of One-Stop Coronary And Myocardial Assessment—Evidence Synthesis And Meta-Analysis Of Correlation. Journal Of Cardiovascular Computed Tomography 2026, 20 DOI: 10.1016/j.jcct.2026.05.207.Peer-Reviewed Original ResearchPericoronary Inflammation Metrics On Coronary Cta (fai/pcat Attenuation) For Hfpef Endotyping And Risk Prediction: Evidence Synthesis Of Diagnostic And Prognostic Cohorts
Siddique T, Sharma A, Kumar H, Rimza F, Gupta S. Pericoronary Inflammation Metrics On Coronary Cta (fai/pcat Attenuation) For Hfpef Endotyping And Risk Prediction: Evidence Synthesis Of Diagnostic And Prognostic Cohorts. Journal Of Cardiovascular Computed Tomography 2026, 20 DOI: 10.1016/j.jcct.2026.05.137.Peer-Reviewed Original ResearchLeft Atrial Function From Routine Cardiac Ct Angiography Predicts Heart-Failure Hospitalization And Cardiovascular Death: Evidence Synthesis Anchored In A Large Longitudinal Ccta Cohort
Sharma A, Kumar H, Rimza F, Gupta S. Left Atrial Function From Routine Cardiac Ct Angiography Predicts Heart-Failure Hospitalization And Cardiovascular Death: Evidence Synthesis Anchored In A Large Longitudinal Ccta Cohort. Journal Of Cardiovascular Computed Tomography 2026, 20 DOI: 10.1016/j.jcct.2026.05.150.Peer-Reviewed Original Research
2019
SYNTHETIC ANGIOTENSIN II EXACERBATION OF SEPTIC MYOCARDITIS, CAUTIOUS UTILIZATION OF NOVEL VASOPRESSOR PHARMACEUTICALS
Horblitt A, Jain D, Kabra N, Jolly G, Gupta S, Dhaduk K. SYNTHETIC ANGIOTENSIN II EXACERBATION OF SEPTIC MYOCARDITIS, CAUTIOUS UTILIZATION OF NOVEL VASOPRESSOR PHARMACEUTICALS. Journal Of The American College Of Cardiology 2019, 73: 2600. DOI: 10.1016/s0735-1097(19)33206-1.Peer-Reviewed Original ResearchCitationsDrug Therapy of Dyslipidemia in the Elderly
Yandrapalli S, Gupta S, Andries G, Cooper H, Aronow W. Drug Therapy of Dyslipidemia in the Elderly. Drugs & Aging 2019, 36: 321-340. PMID: 30613912, DOI: 10.1007/s40266-018-00632-x.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAtherosclerotic cardiovascular diseaseProprotein convertase subtilisin-kexin type 9Atherosclerotic cardiovascular disease riskDrug therapyCardiovascular diseaseSecondary risk reduction strategiesBenefit:risk ratioPrimary preventionPrevention of atherosclerotic cardiovascular diseaseAbnormal lipoprotein metabolismManagement of dyslipidemiaTherapy of dyslipidemiaAdverse cardiovascular outcomesModifiable risk factorsRisk of deathYears of ageTolerated doseCombination therapyStatin therapyPotential adverse effectsDyslipidemia therapyOptimal drugDrug combinationsCardiovascular outcomesGuideline criteria
2018
Investigational drugs for the treatment of acute myocardial infarction: focus on antiplatelet and anticoagulant agents
Yandrapalli S, Andries G, Gupta S, Dajani A, Aronow W. Investigational drugs for the treatment of acute myocardial infarction: focus on antiplatelet and anticoagulant agents. Expert Opinion On Investigational Drugs 2018, 28: 223-234. PMID: 30580647, DOI: 10.1080/13543784.2019.1559814.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsTreatment of acute myocardial infarctionP2Y12 inhibitorsAcute myocardial infarctionAnticoagulant agentsArmamentarium of pharmacological agentsMyocardial infarctionReduction of ischemic eventsComplex pathophysiological mechanismsAnticoagulant rivaroxabanAntiplatelet agentsMEDLINE searchIschemic eventsPathophysiological mechanismsAntithrombotic drugsPharmacological agentsEvaluation of agentsAnticoagulant drugsAcute phaseAtherosclerotic plaque ruptureAntiplateletExpert guidelinesInvestigational drugsRelevant articlesPlaque ruptureAnticoagulationROLE OF POLYMERASE CHAIN REACTION TO DIAGNOSE PORPHYROMONAS GINGIVALIS CULTURE NEGATIVE ENDOCARDITIS
Andries G, Ponce L, Gupta S, Cooper H. ROLE OF POLYMERASE CHAIN REACTION TO DIAGNOSE PORPHYROMONAS GINGIVALIS CULTURE NEGATIVE ENDOCARDITIS. Journal Of The American College Of Cardiology 2018, 71: a2300. DOI: 10.1016/s0735-1097(18)32841-9.Peer-Reviewed Original ResearchMETHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS CAUSING PURULENT PERICARDITIS IN THE SETTING OF INTRAVENOUS DRUG USE
Chawla L, Katchi T, Koulova A, Kabra N, Gupta S, Yandrapalli S, Lanier G, Cooper H. METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS CAUSING PURULENT PERICARDITIS IN THE SETTING OF INTRAVENOUS DRUG USE. Journal Of The American College Of Cardiology 2018, 71: a2337. DOI: 10.1016/s0735-1097(18)32878-x.Peer-Reviewed Original ResearchWOLFF PARKINSON-WHITE SYNDROME CAUSING NON-ST ELEVATION MYOCARDIAL INFARCTION
Gupta S, Khan M, Jolly G, Horblitt A, Katchi T, Andries G, Kaple R, Jacobson J. WOLFF PARKINSON-WHITE SYNDROME CAUSING NON-ST ELEVATION MYOCARDIAL INFARCTION. Journal Of The American College Of Cardiology 2018, 71: a2599. DOI: 10.1016/s0735-1097(18)33140-1.Peer-Reviewed Original Research
Get In Touch
Copy Link